Stay updated on Cannabinoids in Children with ASD Clinical Trial
Sign up to get notified when there's something new on the Cannabinoids in Children with ASD Clinical Trial page.

Latest updates to the Cannabinoids in Children with ASD Clinical Trial page
- CheckyesterdayChange DetectedUI refresh: the page design was updated from revision v3.3.3 to v3.3.4; the study results section and information remain unchanged.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAdded a site revision note 'Revision: v3.3.3' and removed the 'HHS Vulnerability Disclosure' link and the 'Revision: v3.3.2' reference. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedPublications section updated to clarify that entries are pulled from PubMed; the previous wording about PubMed-listed publications has been replaced with updated phrasing. No substantive changes to the study data or status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check58 days agoChange DetectedThe government funding lapse and operating status notice at the top of the page was removed.SummaryDifference0.8%

- Check72 days agoChange DetectedThe page shows a visual redesign (header and layout) while core content about study results remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check101 days agoChange DetectedAdded broader government-operation notices and FDAAA 801 guidance links; updated software revision to v3.2.0. Removed older, narrower study-results sentence and the old revision tag v3.1.0.SummaryDifference17%

Stay in the know with updates to Cannabinoids in Children with ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cannabinoids in Children with ASD Clinical Trial page.